PE20051158A1 - PHARMACEUTICAL COMPOSITIONS INCLUDING A COMBINATION OF EPINASTIN AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE ROUGH DRUGS - Google Patents

PHARMACEUTICAL COMPOSITIONS INCLUDING A COMBINATION OF EPINASTIN AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE ROUGH DRUGS

Info

Publication number
PE20051158A1
PE20051158A1 PE2005000324A PE2005000324A PE20051158A1 PE 20051158 A1 PE20051158 A1 PE 20051158A1 PE 2005000324 A PE2005000324 A PE 2005000324A PE 2005000324 A PE2005000324 A PE 2005000324A PE 20051158 A1 PE20051158 A1 PE 20051158A1
Authority
PE
Peru
Prior art keywords
epinastin
rough
drugs
combination
pharmaceutical compositions
Prior art date
Application number
PE2005000324A
Other languages
Spanish (es)
Inventor
Minoru Okada
Tetsuo Hayashi
Norimitsu Umehara
Shinichiro Katsuyama
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20051158A1 publication Critical patent/PE20051158A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234—Cnidium (snowparsley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538—Schizonepeta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994—Coix (Job's tears)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE (A) EPINASTINA O SUS SALES PRESENTE(S) EN UN INTERVALO DE 1 A 50 mg; (B1) UNO O MAS MINERALES COMO CALCIO, CINC, FOSFORO, ENTRE OTROS, PRESENTE(S) EN UN INTERVALO DE 3 mg A 4000 mg; O (B2) UNO O MAS FARMACOS BRUTOS COMO AJENJO OLOROSA, FRUTO DE GARDENIA, RUIBARBO, HIEDRA, FLOR DE MAGNOLIA, ENTRE OTROS, PRESENTE(S) EN UNA INTERVALO DE 5 mg A 30000 mg. DICHOS COMPUESTOS SON EFICACES EN EL TRATAMIENTO DE ENFERMEDADES DE LA PIELREFERRING TO A PHARMACEUTICAL COMPOSITION INCLUDING (A) EPINASTIN OR ITS SALTS PRESENT (S) IN A RANGE OF 1 TO 50 mg; (B1) ONE OR MORE MINERALS SUCH AS CALCIUM, ZINC, PHOSPHORUS, AMONG OTHERS, PRESENT (S) IN A RANGE OF 3 mg TO 4000 mg; OR (B2) ONE OR MORE ROUGH DRUGS SUCH AS OLOROSA GARLIC, GARDENIA FRUIT, RUIBARB, IVY, MAGNOLIA FLOWER, AMONG OTHERS, PRESENT (S) IN AN INTERVAL OF 5 mg TO 30,000 mg. SUCH COMPOUNDS ARE EFFECTIVE IN THE TREATMENT OF SKIN DISEASES

PE2005000324A 2004-03-24 2005-03-22 PHARMACEUTICAL COMPOSITIONS INCLUDING A COMBINATION OF EPINASTIN AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE ROUGH DRUGS PE20051158A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04007079 2004-03-24
EP04007080 2004-03-24

Publications (1)

Publication Number Publication Date
PE20051158A1 true PE20051158A1 (en) 2006-02-16

Family

ID=34962279

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000324A PE20051158A1 (en) 2004-03-24 2005-03-22 PHARMACEUTICAL COMPOSITIONS INCLUDING A COMBINATION OF EPINASTIN AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE ROUGH DRUGS

Country Status (5)

Country Link
EP (1) EP1735001A2 (en)
JP (1) JP2007530481A (en)
AR (1) AR049876A1 (en)
PE (1) PE20051158A1 (en)
WO (1) WO2005089803A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2079460B1 (en) * 2006-10-20 2018-11-21 NUTRICOS Technologies Cosmetic oral use of glucosamine optionally in combination with at least one polyphenol compound
WO2008074896A1 (en) * 2006-12-21 2008-06-26 Prendergast Patrick T Compositions and methods for treatment of chronic neurological disorders
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
JP5291324B2 (en) * 2007-11-01 2013-09-18 沢井製薬株式会社 Orally disintegrating tablets
JP6009791B2 (en) * 2012-03-28 2016-10-19 ホーユー株式会社 HDC activation inhibitor, HDC activation inhibitor composition, antipruritic agent and antipruritic composition
RU2521247C2 (en) * 2012-06-15 2014-06-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия имени В.Я. Горина" METHOD OF TREATING BOVINE DIGITAL DERMATITIS (Dermatitis digitalis)
WO2014148136A1 (en) * 2013-03-19 2014-09-25 岐阜市 Compound having anti-allergic activity and use of same
CN103977243B (en) * 2014-06-06 2018-01-23 青岛市中心医院 A kind of medicine for treating uremia refractory pruritus and preparation method thereof
CN104547157A (en) * 2015-01-29 2015-04-29 陈文斌 External application preparation for repairing caesarean wound scar and preparation method thereof
JP7205074B2 (en) * 2017-05-02 2023-01-17 大正製薬株式会社 solid composition
CN108355090A (en) * 2018-04-11 2018-08-03 贵阳中医学院第二附属医院 A kind of drug and preparation method thereof for treating pruitus
CN112546204A (en) * 2019-09-10 2021-03-26 蔡娟 Oral care solution for treating hand-foot-and-mouth disease and dental ulcer and preparation method thereof
EP4268827A1 (en) * 2020-12-24 2023-11-01 Santen Pharmaceutical Co., Ltd. Pharmaceutical composition for topical administration containing epinastine or salt thereof
CN116022757A (en) * 2022-12-26 2023-04-28 中南大学 Preparation method of battery-grade hydrated ferric phosphate

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0578243A (en) * 1990-12-11 1993-03-30 Shiseido Co Ltd Antipruritic agent and antipruritic composition
JPH07138173A (en) * 1993-11-15 1995-05-30 Kuga Takaaki Therapeutic agent for dermatopathy such as atopic dermatitis
JPH09208451A (en) * 1995-11-27 1997-08-12 Arusoa Oushiyou:Kk Anti-inflammatory agent for atopic constitution
JPH11100320A (en) * 1997-09-29 1999-04-13 Risuburan:Kk Preparation for external use for skin
JPH11158024A (en) * 1997-11-25 1999-06-15 Kobe Keiei Plan Kk Preparation of beautiful skin
DK1041990T3 (en) * 1997-12-23 2006-10-02 Schering Corp Composition for the treatment of respiratory and skin diseases with at least one leukotriene antagonist and at least one antihistamine
DE19831798A1 (en) * 1998-07-15 2000-01-27 Mandorlo Investment Gmbh Luxem Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
JP4880816B2 (en) * 2000-12-15 2012-02-22 株式会社ヤクルト本社 Skin anti-aging agent
EP1391201A4 (en) * 2001-05-25 2004-06-30 Ssp Co Ltd Medicinal compositions
DE10152973A1 (en) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int New dry and watery Epinastin syrup formulation
JP2003146892A (en) * 2001-11-08 2003-05-21 Rohto Pharmaceut Co Ltd Cleaning agent
JP2006501211A (en) * 2002-08-02 2006-01-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Pharmaceutical composition containing a combination of epinastine, pseudoephedrine and methylephedrine
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases

Also Published As

Publication number Publication date
JP2007530481A (en) 2007-11-01
AR049876A1 (en) 2006-09-13
WO2005089803A3 (en) 2006-11-16
EP1735001A2 (en) 2006-12-27
WO2005089803A2 (en) 2005-09-29

Similar Documents

Publication Publication Date Title
PE20051158A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING A COMBINATION OF EPINASTIN AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE ROUGH DRUGS
GT200400126A (en) ANTITRANSPIRING ACTIVE COMPOUNDS OF ALUMINUM / ZIRCONY / GLYCINE, STABILIZED WITH BETAIN
CY1118519T1 (en) COMPOSITION OF TETRACYCLINS AND THEIR analogues
GT200800184A (en) AMINOTETRAHYDROPIRANS AS INHIBITORS OF DIPEPTIDIL PEPTIDASA-IV FOR THE TREATMENT OR PREVENTION OF DIABETES.
ECSP067120A (en) 3-AMINOCICLOPENTANOCARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS
UY29406A1 (en) GAMMA CRYSTAL FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
BR112015010663A2 (en) sustained release ruxolitinib dosage forms
PE20081506A1 (en) ANSAMYCIN FORMULATIONS
UY28757A1 (en) SUBSTITUTED PIRAZOLINE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICATIONS
UY29407A1 (en) GAMMA-D CRYSTAL FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
ECSP066990A (en) FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO
UY28473A1 (en) NEW COMPOUNDS
ATE543491T1 (en) COMBINATION PREPARATION CONTAINING IBUPROFEN AND PARACETAMOL
ATE410424T1 (en) SPIROCYCLIC CYCLOHEXANE DERIVATIVES
ECSP088811A (en) ORGANIC COMPOUNDS AND THEIR USES
UY30762A1 (en) SMOKE SALT OF (ALFA S, BETA R) -6-BROMO-ALFA- [2 (DIMETILAMINO) ETIL] -2-METOXI-ALFA-1-NAFTALENIL-BETA-PHENYL-3-QUINOLINAETHANOL
TR201909277T4 (en) Rasagiline extended release formulations and uses.
SG178975A1 (en) Indenone derivative and pharmaceutical composition comprising same
CL2011002766A1 (en) Carboxamide derived compounds, calpain inhibitors; pharmaceutical composition comprising them; and its use in the treatment of neurodegenerative diseases, alzahimer, pain, among others.
GT200400218A (en) SUSTAINED RELEASE FORMULATIONS.
PE20051156A1 (en) ORAL MATRIX FORMULATIONS INCLUDING LICARBAZEPINE
DOP2006000280A (en) NEW SUBSTITUTED ACYCLIC FUROPIRIMIDINE DERIVATIVES AND THEIR USE
ES2422730T3 (en) Tiotropium salts, procedure for its preparation, as well as formulations of medicines that contain
BRPI0410044B8 (en) dosage form containing pantoprazole as active ingredient
AR042677A1 (en) ORAL CARE COMPOSITIONS AND METHODS

Legal Events

Date Code Title Description
FC Refusal